Innocan Pharma Corporation: Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue
HERZLIYA, Israel and CALGARY, Alberta, April 18, 2023 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology
Source: finanznachrichten.de